CohBar, Inc.   Report issue

For profit Phase 1
Founded: Pasadena CA United States (2007)
Status: Left NME R&D (2023)

Organization Overview

First Clinical Trial
2018
NCT03998514
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

CohBar, Inc.

Active Ingredients

Drugs in Phase 1 Trials (1)

cb4211 (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Fatty Liver (Phase 1)

Liver Diseases (Phase 1)

Non-alcoholic Fatty Liver Disease (Phase 1)

Overview

  • Highest Phase: Phase 1
  • # of Trials: 1
  • # of Trial APIs: 1